Home > News & Commentary

News & Commentary

Latest News Videos

Danone's Diary Deal With China
Danone's Diary Deal With China      
Apple and Google Dominate Global Brands Survey
Apple and Google Dominate Global Br...
Vodafone's Verizon Dilemma
Vodafone's Verizon Dilemma          
Tumblr Puts Focus on NY Tech Scene
Tumblr Puts Focus on NY Tech Scene  

Moving the Market

 Briefing.com - LIVE market analysis Market Summary  | Stocks On The Move
5/21/2013 11:00 AM ET
[BRIEFING.COM][BRIEFING.COM] The major averages have slipped to their lows, but the losses have been limited. The Nasdaq trades lower by 0.2% while the Dow remains in the black.

The underperformance of the Nasdaq results from cautious trade in technology. The...

[more]

Stock Market Headlines


Manhattan Associates Launches Industry-Leading Store Inventory and Fulfillment Solution   11:00AM ET  - GlobeNewswire

LPL Financial Issues Statement on Settlement With FINRA   10:48AM ET  - GlobeNewswire

UPDATE: Dimon Poised to Survive Challenge at J.P. Morgan   10:47AM ET  - Dow Jones Business News

Argentina Miners Pack Up Picks As Country Loses Its Luster   10:44AM ET  - Dow Jones Business News

MARKET SNAPSHOT: U.S. Stocks Waver Ahead Of Fed Speakers   10:44AM ET  - Dow Jones Business News

View All

Browse News by Category

Business

More Business

Economy

More Economy

Technology

More Technology

U.S. Markets

More U.S. Markets

International

More International

Initial Public Offerings (IPOs)

More IPOs
RSS RSS user? View available RSS feeds in News.




Market Currents Market Currents

Real-time news and commentary for investors

  • 11:03 AM   Chembio Diagnostics ([[CEMI]] +4.1%) gains after entering into an international assembly and distribution agreement with Labtest Diagnostica SA, a leading diagnostics manufacturer and marketing organization in Brazil, for products based upon its patented Dual Path Platform in Brazil and potentially other markets in the region as well. Both companies plan to immediately begin product registration for an initial group of infectious disease products with sales expected to commence by early 2014.
  • See All Market Currents